We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Phase 2 study shows improved survival rates post-neoadjuvant pembrolizumab in muscle-invasive bladder cancer, indicating promising treatment potential.
No takes yet. Share an insight, caveat, or question.
Tateo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: